New Inteleos features gives users the ability to tailor information

December 06, 2006

Amsterdam, December 6, 2006 -- Elsevier, a world-leading healthcare and scientific publisher, announced today new features for its drug tracking and analysis tool, Inteleos. These features enable users to search drug records by Mechanism of Action and Drug Class, graphically chart competitor drugs using a new analysis tool, and search and review clinical trial reports from ClinicalTrials.gov. Users can increase productivity and improve results by specifically tailoring information to meet their business needs.

By indexing Mechanism of Action terms and creating a searchable Drug Class field, Inteleos increases the flexibility of its search and analysis features. The Competitive Grid analysis tool graphically charts competitor drugs per therapy area and allows for comparisons by mechanism of action or drug class, creating dynamic results instantly. Using information reported by ClinicalTrials.gov users can identify and analyze clinical trials across industry, government and academia. Users can also view key trial details specific to drug records.

"Our team continues to show real commitment to customer focus. Improvements made to Inteleos are based on industry feedback; users tell us what they need - the type of information and the format - to improve their business decision-making and we strive to meet these needs" says Julie Gordon, Director of Inteleos, Elsevier. "The inclusion of the Drug Class feature enhances the flexibility and breadth of searching and analysis possible and this is actualized by the Competitor Grid analysis tool. Trial information, via ClinicalTrials.gov, further expands our service into the clinical environment and is the starting point for future enhancements, as customers tell us this is an area of critical need."

In the coming months, Inteleos will enhance services for BizInt customers by enabling the export of Inteleos data into BizInt Smart Charts.
-end-
About Inteleos
Inteleos provides business intelligence support to professionals working in or providing services to the pharmaceutical and biotech industries. Inteleos tracks drug development and associated licensing activities from late-stage preclinical through to launch and post-marketing studies. In addition to critical drug development information, Inteleos provides easy-to-use analysis tools to support decision-making and drive strategy. Inteleos is powered by AdvanTechnologies, Inc.

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Elsevier

Related Business Articles from Brightsurf:

3D printing -- a 'dusty' business?
3D printers are becoming increasingly popular. They can be used to create a wide variety of three-dimensional objects based on computer templates.

Business-to-business customers expect personal service in online chat
Companies engaged in business-to-business (B2B) sales are also increasingly moving their activities online, but their online chat services and customer interaction have not been studied much yet.

Entrepreneurs have different storytelling styles for presenting business
New pioneering research shows that entrepreneurs communicate to strengthen their professional image and stakeholder relationships -- and avoid blaming others.

Gender quotas in business -- how do Europeans feel?
Despite years trying to bring more women to the top boards of business, the proportion of women on the committees of companies is tiny.

Carbon dioxide capture and use could become big business
Capturing carbon dioxide and turning it into commercial products, such as fuels or construction materials, could become a new global industry, according to a study by researchers from UCLA, the University of Oxford and five other institutions.

How NASA is becoming more business friendly
A new case study demonstrates the steps being taken by the US National Aeronautics and Space Agency (NASA) to make it easier for small businesses and entrepreneurs to understand its needs and do business with it.

Finding the 'Goldilocks' level of enthusiasm for business pitches
Georgia Institute of Technology researchers found how long an entrepreneur displays the highest level of excitement during a pitch also plays a major role in predicting success in receiving funding.

Bosses who put their followers first can boost their business
Companies would do well to tailor training and recruitment measures to encourage managers who have empathy, integrity and are trustworthy -- because they can improve productivity, according to new research from the University of Exeter Business School.

Bacteria rely on classic business model
The pneumonia causing pathogen Pseudomonas aeruginosa has developed a twin-track strategy to colonize its host.

Even small gifts boost business
If a sales agent brings their customer a small gift, the customer is much more likely to make a purchase, a study by the university of Zurich has shown.

Read More: Business News and Business Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.